Eptifibatide: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Intervention and Acute Coronary Syndromes
Year of publication: |
2003
|
---|---|
Authors: | Plosker, Greg L. ; Ibbotson, Tim |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 21.2003, 12, p. 885-912
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Acute-coronary-syndromes | Adis-Drug-Evaluations | Antiplatelets | Coronary-interventions | Eptifibatide | GPIIb-IIIa-antagonists |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Bosanquet, Nick, (2003)
-
Spotlight on Eptifibatide in Percutaneous Coronary Intervention and Acute Coronary Syndromes
Plosker, Greg L., (2004)
-
Bivalirudin: A Pharmacoeconomic Profile of its Use in Patients with Acute Coronary Syndromes
Lyseng-Williamson, Katherine A., (2011)
- More ...
-
Spotlight on Eptifibatide in Percutaneous Coronary Intervention and Acute Coronary Syndromes
Plosker, Greg L., (2004)
-
Management of Alzheimer's Disease: Defining the Role of Donepezil
Ibbotson, Tim, (2002)
-
Management of Parkinson's Disease: Defining the Role of Entacapone
Ibbotson, Tim, (2002)
- More ...